Latest Post

August 24, 2020

How to Include Elastomers in the Nitrosamine Risk Assessment

Putting together a risk assessment for nitrosamines in your final drug product is an extensive undertaking. Many contributing factors need to be considered, such as the drug substance’s manufacturing process, excipients, buffers, water, production equipment and environment, transportation conditions, packaging, and more. Within this scope, primary packaging components, such as elastomeric closures, also could contribute nitrosamines or precursors.
Bettine Boltres

Dr. Bettine Boltres

Principal Scientific Affairs, Packaging & Delivery Systems


Search the Blog





  • Previous Posts
    AccelTRA Components Program

    June 26, 2020

    Performance of AccelTRA® Components

    Qian Liu

    Nancy Liu

    Senior Specialist, TCS, China

    By Your Side for Collaboration

    July 24, 2019

    Scientific Insight Enables Risk Mitigation: Why West is By our Customers’ Side

    Fran DeGrazio

    Fran DeGrazio

    Vice President, Technical Services & Scientific Affairs

    West logo with Diamond

    March 12, 2012

    Managing Total Cost of Ownership in a Changing Market

    West Pharma

    Fran DeGrazio

    VP, Scientific Affairs & Technical Services